Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
Alireza Mohajjel Nayebi, Hassan Rezazadeh, Mostafa Nourafka. Buspirone attenuates tolerance to analgesic effect of morphine in mice with skin cancer. Pakistan journal of pharmaceutical sciences. vol 23. issue 2. 2010-06-03. PMID:20363700. |
this study was aimed to investigate effect of buspirone, as a partial agonist of 5-ht1a receptor, on tolerance induced to morphine analgesic effect in animals with skin cancer. |
2010-06-03 |
2023-08-12 |
mouse |
George I Papakostas, Sarah E Chuzi, Jessica L Sousa, Maurizio Fav. 5HT1A-mediated stimulation of cortisol release in major depression: use of non-invasive cortisol measurements to predict clinical response. European archives of psychiatry and clinical neuroscience. vol 260. issue 2. 2010-05-26. PMID:19641981. |
we examined whether the sensitivity of the 5ht1a receptor, as measured by the difference in salivary cortisol levels immediately before and 90 min following the administration of a single dose of the 5ht1a-selective agonist buspirone, predicted treatment outcome following an 8-week, fixed-dose, open trial of the ssri escitalopram in 17 outpatients with mdd. |
2010-05-26 |
2023-08-12 |
Not clear |
V Coiro, M L Maffei, E Volta, S Cataldo, R Minelli, P Vacca, R Volpi, P Chioder. Effect of serotonergic system on AVP secretion induced by physical exercise. Neuropeptides. vol 44. issue 1. 2010-04-08. PMID:19914713. |
twenty-one healthy men (divided in three groups of seven) underwent bicycle-ergometer tests until exhaustion: exercise control test (n=21), exercise plus ondansetron, selective 5-ht3 antagonist (n=7), exercise plus buspirone, selective 5-ht1a receptor agonist (n=7), exercise plus sumatriptan, selective 5-ht1d receptor agonist (n=7). |
2010-04-08 |
2023-08-12 |
Not clear |
Osman Sabuncuoglu, Ozalp Ekinci, Meral Berke. Fluoxetine-induced sleep bruxism in an adolescent treated with buspirone: a case report. Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry. vol 29. issue 5. 2009-12-23. PMID:19740153. |
this may be prevented by using buspirone, a 5-ht1a agonist that reduces serotonergic activity and increases dopaminergic activity. |
2009-12-23 |
2023-08-12 |
Not clear |
Susan A Brunelli, Jessica A Aviles, Kimberly S Gannon, Aron Branscomb, Sharon Shacha. PRX-00023, a selective serotonin 1A receptor agonist, reduces ultrasonic vocalizations in infant rats bred for high infantile anxiety. Pharmacology, biochemistry, and behavior. vol 94. issue 1. 2009-12-17. PMID:19576924. |
in this study, rates of usv in high line infants (pups: postnatal day 11+/-1) were compared to those of randomly-bred controls in response to epix compound prx-00023, a unique serotonin (5-ht) agonist, acting exclusively at the 5-ht1a receptor, or buspirone, a nonspecific 5ht1a agonist. |
2009-12-17 |
2023-08-12 |
rat |
Hiroto Miwa, A Nagahara, K Tominaga, T Yokoyama, Y Sawada, K Inoue, Kiyoshi Ashida, T Fukuchi, M Hojo, H Yamashita, T Tomita, K Hori, T Oshim. Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial. The American journal of gastroenterology. vol 104. issue 11. 2009-12-01. PMID:19638966. |
efficacy of the 5-ht1a agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial. |
2009-12-01 |
2023-08-12 |
Not clear |
Hiroto Miwa, A Nagahara, K Tominaga, T Yokoyama, Y Sawada, K Inoue, Kiyoshi Ashida, T Fukuchi, M Hojo, H Yamashita, T Tomita, K Hori, T Oshim. Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial. The American journal of gastroenterology. vol 104. issue 11. 2009-12-01. PMID:19638966. |
the aim of this study was to examine the efficacy of tandospirone citrate, a new partial agonist of the 5-hydroxytryptamine 1a (5-ht1a) receptor, in improving the symptoms of patients with fd. |
2009-12-01 |
2023-08-12 |
Not clear |
Goran Pavlaković, Julija Tigges, Thomas A Crozie. Effect of buspirone on thermal sensory and pain thresholds in human volunteers. BMC clinical pharmacology. vol 9. 2009-09-25. PMID:19480657. |
buspirone is a partial 5-ht1a receptor agonist. |
2009-09-25 |
2023-08-12 |
human |
Rakesh Kumar, Lindsay Riddle, Suzy A Griffin, Peter Grundt, Amy Hauck Newman, Robert R Luedtk. Evaluation of the D3 dopamine receptor selective antagonist PG01037 on L-dopa-dependent abnormal involuntary movements in rats. Neuropharmacology. vol 56. issue 6-7. 2009-07-07. PMID:19371585. |
for the initial experiments, the 5-ht1a receptor selective partial agonist buspirone was used as a positive control to verify our ability to quantitate changes in total aims and aims minus locomotor scores. |
2009-07-07 |
2023-08-12 |
human |
Rakesh Kumar, Lindsay R Riddle, Suzy A Griffin, Wenhua Chu, Suwanna Vangveravong, Janet Neisewander, Robert H Mach, Robert R Luedtk. Evaluation of D2 and D3 dopamine receptor selective compounds on L-dopa-dependent abnormal involuntary movements in rats. Neuropharmacology. vol 56. issue 6-7. 2009-07-07. PMID:19371586. |
for the initial experiments the 5-ht1a receptor selective partial agonist buspirone was used to verify our ability to quantitate changes in total aims and aims minus locomotor scores. |
2009-07-07 |
2023-08-12 |
human |
Marta Grabiec, Kris Turlejski, Rouzanna L Djavadia. The partial 5-HT1A receptor agonist buspirone enhances neurogenesis in the opossum (Monodelphis domestica). European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 19. issue 6. 2009-06-25. PMID:19249192. |
the partial 5-ht1a receptor agonist buspirone enhances neurogenesis in the opossum (monodelphis domestica). |
2009-06-25 |
2023-08-12 |
human |
Marta Grabiec, Kris Turlejski, Rouzanna L Djavadia. The partial 5-HT1A receptor agonist buspirone enhances neurogenesis in the opossum (Monodelphis domestica). European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 19. issue 6. 2009-06-25. PMID:19249192. |
treatment with buspirone, a partial 5-ht1a receptor agonist which is used in human clinic as an anxiolytic agent, boosts proliferation in the svz and dg in both adult and aged opossums. |
2009-06-25 |
2023-08-12 |
human |
Yukihiro Ohno, Saki Shimizu, Junta Imak. Effects of tandospirone, a 5-HT1A agonistic anxiolytic agent, on haloperidol-induced catalepsy and forebrain Fos expression in mice. Journal of pharmacological sciences. vol 109. issue 4. 2009-06-22. PMID:19352073. |
effects of tandospirone, a 5-ht1a agonistic anxiolytic agent, on haloperidol-induced catalepsy and forebrain fos expression in mice. |
2009-06-22 |
2023-08-12 |
mouse |
Yukihiro Ohno, Saki Shimizu, Junta Imaki, Shizuka Ishihara, Nobumasa Sofue, Masashi Sasa, Yoshiko Kawa. Evaluation of the antibradykinetic actions of 5-HT1A agonists using the mouse pole test. Progress in neuro-psychopharmacology & biological psychiatry. vol 32. issue 5. 2008-11-05. PMID:18495311. |
the selective 5-ht1a agonists, 8-hydroxydipropylaminotetraline (8-oh-dpat) and tandospirone, significantly attenuated haloperidol-induced bradykinesia in a dose-dependent manner. |
2008-11-05 |
2023-08-12 |
mouse |
Masanori Nagamine, Aihide Yoshino, Masaki Miyazaki, Yoshitomo Takahashi, Soichiro Nomur. Effects of selective 5-HT1A agonist tandospirone on the rate and rhythmicity of binocular rivalry. Psychopharmacology. vol 198. issue 2. 2008-10-23. PMID:18408919. |
effects of selective 5-ht1a agonist tandospirone on the rate and rhythmicity of binocular rivalry. |
2008-10-23 |
2023-08-12 |
Not clear |
Motoo Yamauchi, Hasan Ocak, Jesse Dostal, Frank J Jacono, Kenneth A Loparo, Kingman P Stroh. Post-sigh breathing behavior and spontaneous pauses in the C57BL/6J (B6) mouse. Respiratory physiology & neurobiology. vol 162. issue 2. 2008-10-21. PMID:18565803. |
a 5-ht1a receptor agonist (buspirone) and a chromosomal substitution strain (b6a1) were used to further alter breathing patterning. |
2008-10-21 |
2023-08-12 |
mouse |
S O'Mahony, A S B Chua, E M M Quigley, G Clarke, F Shanahan, P W N Keeling, T G Dina. Evidence of an enhanced central 5HT response in irritable bowel syndrome and in the rat maternal separation model. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society. vol 20. issue 6. 2008-10-13. PMID:18194152. |
in study 1, 10 ibs patients and 10 controls underwent pretreatment with pindolol (5ht1a antagonist) or placebo followed by buspirone. |
2008-10-13 |
2023-08-12 |
rat |
Motoo Yamauchi, Jesse Dostal, Hiroshi Kimura, Kingman P Stroh. Effects of buspirone on posthypoxic ventilatory behavior in the C57BL/6J and A/J mouse strains. Journal of applied physiology (Bethesda, Md. : 1985). vol 105. issue 2. 2008-10-10. PMID:18511527. |
buspirone, a partial agonist of the serotonergic 5-ht1a receptor, improves breathing irregularities in humans with rett syndrome or brain stem injury. |
2008-10-10 |
2023-08-12 |
mouse |
Motoo Yamauchi, Jesse Dostal, Hiroshi Kimura, Kingman P Stroh. Effects of buspirone on posthypoxic ventilatory behavior in the C57BL/6J and A/J mouse strains. Journal of applied physiology (Bethesda, Md. : 1985). vol 105. issue 2. 2008-10-10. PMID:18511527. |
on a separate day, mice were injected with the 5-ht1a receptor antagonist 4-iodo-n-{2-[4-(methoxyphenyl)-1-piperazinyl] ethyl}-n-2-pyridinylbenzamide (p-mppi) before the injection of buspirone, and measurements were repeated. |
2008-10-10 |
2023-08-12 |
mouse |
Motoo Yamauchi, Jesse Dostal, Hiroshi Kimura, Kingman P Stroh. Effects of buspirone on posthypoxic ventilatory behavior in the C57BL/6J and A/J mouse strains. Journal of applied physiology (Bethesda, Md. : 1985). vol 105. issue 2. 2008-10-10. PMID:18511527. |
we conclude that buspirone improves posthypoxic ventilatory irregularities in the b6 mouse through its agonist effects on the 5-ht1a receptor. |
2008-10-10 |
2023-08-12 |
mouse |